How we partner.

Provide strategic scientific guidance to biotechnology companies, investors, and founders evaluating new therapeutic opportunities or navigating critical development decisions. We work closely with leadership teams to assess target biology, strengthen translational strategy, evaluate scientific risk, and develop clear, evidence-based paths for advancing drug discovery programs. Engagements are tailored to the needs of each organization, from one-time diligence projects to ongoing scientific advisory relationships.

Typical Engagements

• Scientific and technical due diligence for therapeutic assets and company platforms
• Target evaluation, mechanism-of-action assessment, and biomarker strategy
• Portfolio prioritization and go/no-go recommendations
• Scientific support for investor presentations, partnering discussions, and board meetings

Provide embedded scientific leadership for early-stage biotechnology companies that require experienced drug discovery leadership without the commitment of a full-time executive hire. We integrate with existing teams to help establish scientific strategy, coordinate cross-functional execution, develop cellular and biochemical assay cascades, mentor scientists, and advance programs from target identification through preclinical candidate selection.

Typical Engagements

• 1–3 days per week, scaled to company needs
• Scientific leadership across biology, screening, translational research, pharmacology, and external partners
• Cross-functional program planning, milestone development, and risk management
• Ideal for seed-stage through Series B biotechnology companies building discovery capabilities

Design, evaluate, and optimize genomics and functional genomics capabilities that enable target discovery, mechanism-of-action studies, biomarker development, and translational research. Drawing on experience building genomics platforms in both academia and biotechnology, we help organizations implement scalable technologies, experimental workflows, and data generation strategies aligned with scientific and business objectives.

Typical Engagements

• Functional genomics and transcriptomics strategy
• CRISPR, RNA-seq, single-cell RNA-seq, ChIP-seq, ATAC-seq, and multi-omic workflows
• Assay development, technology evaluation, and CRO selection
• Platform design, workflow optimization, and scientific interpretation

Lead complex discovery programs by establishing clear scientific priorities, coordinating multidisciplinary teams, and maintaining disciplined program execution. We help organizations improve communication, manage external collaborations, and keep programs focused on the experiments that drive the highest-value decisions.

Typical Engagements

• Agile and hybrid program planning, milestone tracking, and decision frameworks
• CRO selection, oversight, and scientific management
• Cross-functional communication across biology, chemistry, pharmacology, and external collaborators
• Executive reporting, scientific presentations, and portfolio updates